The Lightning Round is extended in this CNBC.com exclusive feature.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma. First the bad news.    Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Human Genome and CIT Group popped while BB&T and Weatherford dropped.   Read More

The Dow closed below 10,000 on Friday after disappointing results from GE and BofA suggested the road to economic recovery will be bumpy.   Read More

2,226 percent. That is the astronomical increase in shares of baby biopharma Vanda so far this year. And it's the prime historical example of "Biotech Takeouts and Breakouts" Bernstein's Geoffrey Porges uses in a sequel research note to clients he put out today.    Read More

Following are the week’s biggest winners and losers. Find out why shares of Citigroup and Boeing popped while Research In Motion and Novell dropped.   Read More

As stocks waffled between positive and negative, new signs emerged on Wednesday that the bulls may be losing their grip on this market. Are we heading for a massive correction?   Read More

Following are the day’s biggest winners and losers. Find out why shares of Research In Motion and WMS Industries popped while ADM and Pulte Homes dropped.   Read More